Uveitis, Anterior, Childhood Clinical Presentation

  • Author: R Christopher Walton, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: May 2, 2012
 

History

The main objective in taking the history in children with anterior uveitis is to narrow the differential diagnosis, to optimize laboratory testing, and to direct appropriate referrals.

The parents and the child, if appropriate, should be asked about the presence of arthritis, rashes or other dermatologic disorders, gastrointestinal disease, and asthma or other pulmonary conditions. The history is covered in more detail in the sections covering the specific causes of uveitis.

Next

Physical

As in adult patients with uveitis, a complete examination of the eye and ocular adnexa is essential. Rarely, in younger patients or uncooperative patients, examination under anesthesia may be required.

  • Inspect and palpate the lacrimal gland because it may be enlarged in sarcoidosis and other infiltrative conditions. Similarly, palpate the lymph nodes of the head and neck.
  • When appropriate, inspect the skin of the entire body. Erythema nodosum is common in sarcoidosis but usually does not occur on the face. However, crops of papular eruptions may occur in a periocular distribution as a manifestation of sarcoidosis.
  • Blepharitis and blepharoconjunctivitis may be signs of herpes simplex virus (HSV) infection. Careful inspection of the conjunctiva for granulomata is obviously a key part of the evaluation of any patient with uveitis.
  • Yellow-orange periocular lesions may be a clue that intraocular inflammation is due to juvenile xanthogranuloma (JXG), as well as providing an easily accessible biopsy site.
  • Corneal band keratopathy is often seen in JIA-associated uveitis; it may be quite subtle and limited to the limbal areas of the 3-o'clock and 9-o'clock meridians.
  • Specifically seek evidence of geographic or stellate keratitis suggesting herpes infection; fluorescein or rose bengal staining helps to identify these signs.
  • Mutton-fat keratic precipitates (KP) may be present in granulomatous conditions, but smaller KP occur in JIA-associated and HLA-B27–associated uveitis. Assess anterior chamber cell and flare according to a standard grading scheme.
  • Examine the iris for Koeppe and Busacca nodules, which occur in granulomatous uveitis. Anterior and posterior synechiae suggest prior episodes or a prolonged course and indicate an increased likelihood of glaucoma.
  • Pseudohypopyon may indicate leukemia, retinoblastoma, and JXG.
  • Examine the vitreous for spillover inflammation, and exclude intermediate uveitis and pars planitis.
  • Optic disc edema is uncommon but can occur. The edema typically resolves but often lags behind improvement of the uveitis.[8]
  • Determination of the intraocular pressure is critical but usually does not help to narrow the differential diagnosis.
  • Arthritis and joint tenderness suggest JIA or spondyloarthropathy; limited torso flexion occurs in AS; and the development of a new heart murmur along with fever and rash may suggest Kawasaki disease.
Previous
Next

Causes

  • Juvenile idiopathic arthritis
    • JIA refers to arthritis of unknown cause in a child. The International League of Associations for Rheumatology (ILAR) classification of JIA includes 7 forms of the disease. Categories include systemic, oligoarticular, RF-negative polyarthritis, RF-positive polyarthritis, psoriatic, enthesitis-related, and undefined JIA. In the United States, JIA affects 60,000-70,000 children.
    • Uveitis can develop in children with oligoarthritis, RF-negative polyarthritis, enthesitis-related arthritis, and psoriatic JIA and can lead to long-term complications. A quiet, usually bilateral predominantly anterior uveitis is notorious for causing no symptoms in its early stages. As the inflammation continues, posterior synechiae, cataracts, glaucoma, and band keratopathy occur.
    • Males with JIA have a poorer visual prognosis. Children who develop uveitis prior to the onset of arthritis also have worse visual acuity during the first 3 years following the diagnosis of uveitis.[1, 9]
  • Reactive arthritis
    • The classic description of reactive arthritis is that of a triad of urethritis, conjunctivitis, and arthritis.
    • Acute or chronic nongranulomatous anterior uveitis occurs in reactive arthritis in as many as 30% of cases. Recurrent acute attacks are typical; both eyes are affected but usually not simultaneously. Posterior synechiae, fibrinous exudates, hypopyon formation, and hypotony are common. Spillover vitritis and cystoid macular edema may be seen.
    • The attacks typically last from 2-3 months. In children, disease onset may occur following enteritis due to Salmonella, Shigella, Yersinia, or Campylobacter species. Antecedent chlamydial urethritis has a greater role in adult cases.
    • Approximately 60% of patients have the HLA-B27 haplotype, and males are affected at least 5 times more frequently than females. Within weeks following an inciting infection, a peripheral arthritis develops, typically asymmetrically involving the hands, feet, knees, ankles, and wrists. Other characteristic lesions include superficial oral ulcers, keratoderma blennorrhagica, and balanitis circinata.
  • Ankylosing spondylitis
    • AS is characterized by painful stiffening of the back caused by sacroiliitis and lumbosacral spondylitis. Lower back pain is the usual presenting symptom, although some patients have peripheral arthritis.
    • Of patients with AS, 90% have the HLA-B27 haplotype; however, unlike reactive arthritis, no other specific inciting cause is known.
    • Mean age of onset is 11.5 years, and males are 3 times more commonly affected than females. The uveitis is similar to that seen in reactive arthritis, as follows: recurrent, nongranulomatous anterior uveitis, frequently with fibrinous exudate, hypopyon formation, and posterior synechiae.
  • Ulcerative colitis and Crohn disease
    • Compared to the previously discussed spondyloarthropathies, uveitis occurs less commonly in patients with inflammatory bowel disease. Overall, about 5% of patients develop iritis, which typically is mild anterior nongranulomatous. Patients often are asymptomatic.
    • Episcleritis also may occur in patients with inflammatory bowel disease. Whether the presence of uveitis parallels disease flare-ups is debated. Severe ocular sequelae are uncommon.
  • Childhood sarcoidosis
    • Sarcoidosis is a chronic multisystem disorder with variable clinical manifestations that is uncommon in children.
    • In children younger than 5 years, the clinical manifestations differ from older children with sarcoidosis. In these children, the most common clinical findings include a maculopapular, erythematous rash; uveitis; and polyarticular arthritis. Additionally, pulmonary involvement is uncommon in this group of children.
    • In children 5 years and older, the most common clinical findings include lymphadenopathy, pulmonary abnormalities, and uveitis. The clinical course in these children is similar to that seen in adults with sarcoidosis.
    • Ocular involvement is common in children with sarcoidosis. Anterior uveitis is the most common ocular manifestation in these children. The uveitis may be characterized as granulomatous or nongranulomatous. Ocular findings include KP, iris nodules, cells and flare, and posterior synechiae. Band keratopathy frequently is seen in children with chronic inflammation. Posterior uveitis and disc edema also can occur. Secondary glaucoma is not uncommon and can result in permanent visual loss.
    • Children who have findings suggestive of sarcoidosis should undergo a complete examination by a pediatrician. The examination should include a thorough evaluation of the lungs and a determination of serum and urine calcium levels. Additionally, these children should undergo complete examination by an ophthalmologist.
  • Kawasaki disease
    • Kawasaki disease is a systemic disease of unknown cause affecting children and adolescents. Its major features are protracted fever, cervical lymph node swelling, strawberry tongue (prominence of tongue papillae), palmar erythema, erythematous rash, and bilateral conjunctival injection.
    • Occurrence of uveitis was not recognized in the early descriptions of Kawasaki disease but a self-limited, nongranulomatous anterior uveitis is very common, particularly in the early stages of the disease.
  • Viral-associated diseases (eg, mumps, measles, varicella, mononucleosis): Mild, bilateral nongranulomatous, anterior uveitis is common in systemic viral illnesses such as those noted above. Patients typically are asymptomatic, and the uveitis is self-limited.
  • Rubella virus: Chronic anterior uveitis with stellate keratic precipitates may occur in unvaccinated children. Cataract is not uncommon in these children.[10]
  • Juvenile xanthogranuloma: Intraocular JXG, usually presenting as an iris mass, may produce a picture resembling anterior uveitis. Characteristic yellow-cream lesions of the skin may be present, providing a convenient site to biopsy. Spontaneous hyphema also may occur.
  • Leukemia: Anterior uveitis may rarely signal the onset of or a relapse of leukemia. A hypopyon may be present.
  • Acute tubulointerstitial nephritis and uveitis
    • Acute tubulointerstitial nephritis and uveitis (TINU syndrome) consists of acute interstitial nephritis and uveitis. Most patients are adolescents with a median age of 15 years, although middle-aged and elderly patients have been reported. Most patients exhibit proteinuria, elevated urine beta-2-microglobulin, glucosuria, and sterile pyuria. Serum creatinine is also elevated. Additional findings include fever, weight loss, fatigue, anorexia, anemia, and hypergammaglobulinemia.
    • The most common ocular manifestation of TINU syndrome is an acute bilateral anterior uveitis. The uveitis typically responds to treatment with corticosteroids but may become recurrent. Less common manifestations include vitritis, panuveitis, retinal vasculitis with perivascular sheathing, and rarely multifocal choroiditis.
    • To establish a diagnosis of TINU, the onset of uveitis should occur within a year of the development of acute interstitial nephritis.[11]
  • Poststreptococcal syndrome uveitis: Rarely, bilateral nongranulomatous anterior uveitis can develop 1-8 weeks following group A streptococcal infection.[12] Posterior segment involvement has been reported but is much less common. Antistreptococcal lysin O titers are elevated. Management with pediatric subspecialists is essential (see Consultations).
  • Blau syndrome
    • Familial granulomatous arthritis, iritis, and rash (Blau syndrome) is an autosomal dominant multisystem inflammatory disease first described in 1985.
    • Clinical manifestations of Blau syndrome include arthritis, synovial cysts, camptodactyly, erythematous rash, and uveitis. Clinical findings are similar to those seen in childhood sarcoidosis; however, synovial cysts and camptodactyly have not been described in children with sarcoidosis. Additionally, pulmonary involvement has not been described in children or adults with Blau syndrome.
    • The rash seen in Blau syndrome is a granulomatous erythematous papular eruption described as painless, tiny, red dots often in a generalized distribution. Onset usually is in early childhood, but it can occur as early as age 4 months. In most cases, the rash resolves spontaneously.
    • Joint manifestations typically develop during childhood and often before age 10 years. The earliest joint changes are insidious in onset and include synovial cysts and boutonniere deformities. Painless synovial cysts may develop on the wrists, ankles, or dorsum of the foot. Boutonniere deformities of the fingers are a characteristic finding in these children. These early lesions often progress to camptodactyly and cystic swelling of the wrists, elbows, knees, and ankles.
    • Ocular involvement appears to be the most serious complication of Blau syndrome. Uveitis can develop in childhood or during the early adult years. In most cases, the uveitis initially manifests as a nongranulomatous anterior uveitis; however, the disease often is recurrent and eventually develops into a chronic anterior uveitis. Later in the clinical course, posterior uveitis can occur with vitritis, disc edema, and chorioretinal lesions. Secondary glaucoma is not uncommon and may lead to devastating visual loss.
  • Herpes simplex
    • Uveitis associated with herpes simplex often is accompanied by keratitis, making diagnosis relatively straightforward. Whether the inflammation represents active infection or an immune reaction is an unsettled question.
    • The inflammation may be severe, with pain, KP, and hypopyon formation. Trabeculitis with secondary glaucoma is an important complication.
  • Varicella zoster
    • Varicella zoster in children usually occurs in the setting of immunosuppression, such as in acquired immunodeficiency syndrome (AIDS).
    • Keratitis usually is seen with the uveitis that may occur. The uveitis is believed to result from vasculitis, with resultant vascular occlusion and ischemia.
  • Behçet disease
    • Behçet disease is a systemic vasculitis characterized by recurrent oral aphthous ulcers, genital ulcers, and uveitis. Additional manifestations are variable but may include skin lesions, venous thrombosis, arthritis, and central nervous system symptoms. Most affected patients are aged 25-35 years. However, children can be affected.
    • Children with Behçet disease may develop anterior uveitis, posterior uveitis, or panuveitis. A retrospective report from Turkey found that among children, 33% had anterior uveitis.[13]
Previous
 
 
Contributor Information and Disclosures
Author

R Christopher Walton, MD  Professor, Director of Uveitis and Ocular Inflammatory Disease Service, Department of Ophthalmology, University of Tennessee College of Medicine

R Christopher Walton, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Healthcare Executives, American Uveitis Society, Association for Research in Vision and Ophthalmology, and Retina Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Gerhard W Cibis, MD  Clinical Professor, Director of Pediatric Ophthalmology Service, Department of Ophthalmology, University of Kansas School of Medicine

Gerhard W Cibis, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, and American Ophthalmological Society

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Steve Charles, MD  Director of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine; Adjunct Professor of Ophthalmology, Columbia College of Physicians and Surgeons; Clinical Professor Ophthalmology, Chinese University of Hong Kong

Steve Charles, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Retina Specialists, Club Jules Gonin, Macula Society, and Retina Society

Disclosure: Alcon Laboratories Consulting fee Consulting; OptiMedica Ownership interest Other; Topcon Medical Lasers Consulting fee Consulting

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthor, Peter H Spiegel, MD, to the development and writing of this article.

References
  1. Holland GN, Denove CS, Yu F. Chronic anterior uveitis in children: clinical characteristics and complications. Am J Ophthalmol. Apr 2009;147(4):667-678.e5. [Medline].

  2. Hooper C, McCluskey P. Intraocular inflammation: its causes and investigations. Curr Allergy Asthma Rep. Jul 2008;8(4):331-8. [Medline].

  3. Zaborowski AG, Parbhoo D, Chinniah K, Visser L. Uveitis in children with human immunodeficiency virus-associated arthritis. J AAPOS. Dec 2008;12(6):608-10. [Medline].

  4. Spratt A, Key T, Vivian AJ. Chronic anterior uveitis following bacille Calmette-Guérin vaccination: molecular mimicry in action?. J Pediatr Ophthalmol Strabismus. Jul-Aug 2008;45(4):252-3. [Medline].

  5. Rothova A, Schneider M, de Groot-Mijnes JD. Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads. Ophthalmology. Nov 2008;115(11):2062-4. [Medline].

  6. BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. Apr 2005;89(4):444-8. [Medline].

  7. Zierhut M, Michels H, Stubiger N, Besch D, Deuter C, Heiligenhaus A. Uveitis in children. Int Ophthalmol Clin. 2005;45(2):135-56. [Medline].

  8. Monheit BE, Read RW. Optic disk edema associated with sudden-onset anterior uveitis. Am J Ophthalmol. Oct 2005;140(4):733-5. [Medline].

  9. Ayuso VK, Ten Cate HA, van der Does P, Rothova A, de Boer JH. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. Jun 2010;149(6):987-93. [Medline].

  10. Wensing B, Relvas LM, Caspers LE, Valentincic NV, Stunf S, de Groot-Mijnes JD. Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis. Ophthalmology. Oct 2011;118(10):1905-10. [Medline].

  11. Levinson RD. Tubulointerstitial nephritis and uveitis syndrome. Int Ophthalmol Clin. Summer 2008;48(3):51-9. [Medline].

  12. Ur Rehman S, Anand S, Reddy A, Backhouse OC, Mohamed M, Mahomed I. Poststreptococcal syndrome uveitis: a descriptive case series and literature review. Ophthalmology. Apr 2006;113(4):701-6. [Medline].

  13. Atmaca L, Boyvat A, Yalçindag FN, Atmaca-Sonmez P, Gurler A. Behçet disease in children. Ocul Immunol Inflamm. Apr 2011;19(2):103-7. [Medline].

  14. Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. Jul 2010;117(7):1436-41. [Medline].

  15. Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol. Feb 2011;151(2):217-22. [Medline].

  16. Goebel JC, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. Br J Ophthalmol. Feb 2011;95(2):209-13. [Medline].

  17. Chang PY, Giuliari GP, Shaikh M, Thakuria P, Makhoul D, Foster CS. Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye (Lond). Apr 2011;25(4):427-35. [Medline]. [Full Text].

  18. Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford). Aug 2006;45(8):982-9. [Medline].

  19. Gallagher M, Quinones K, Cervantes-Castañeda RA, Yilmaz T, Foster CS. Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol. Oct 2007;91(10):1341-4. [Medline].

  20. Zierhut M, Doycheva D, Biester S, Stübiger N, Kümmerle-Deschner J, Deuter C. Therapy of uveitis in children. Int Ophthalmol Clin. Summer 2008;48(3):131-52. [Medline].

  21. Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. Mar 2007;91(3):319-24. [Medline].

  22. Nemet AY, Raz J, Sachs D, Friling R, Neuman R, Kramer M. Primary intraocular lens implantation in pediatric uveitis: a comparison of 2 populations. Arch Ophthalmol. Mar 2007;125(3):354-60. [Medline].

  23. Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS. Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology. Feb 2006;113(2):308-14. [Medline].

  24. Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford). Aug 2006;45(8):982-9. [Medline].

  25. Banares A, Hernandez-Garcia C, Fernandez-Gutierrez B, Jover JA. Eye involvement in the spondyloarthropathies. Rheum Dis Clin North Am. Nov 1998;24(4):771-84, ix. [Medline].

  26. de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. Jul 2003;87(7):879-84. [Medline].

  27. Edmunds L, Elswood J, Calin A. New light on uveitis in ankylosing spondylitis. J Rheumatol. Jan 1991;18(1):50-2. [Medline].

  28. Flynn HW Jr, Davis JL, Culbertson WW. Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis. Ophthalmology. Aug 1988;95(8):1114-9. [Medline].

  29. Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. Dec 2003;14(6):395-8. [Medline].

  30. Fox GM, Flynn HW Jr, Davis JL, Culbertson W. Causes of reduced visual acuity on long-term follow-up after cataract extraction in patients with uveitis and juvenile rheumatoid arthritis. Am J Ophthalmol. Dec 15 1992;114(6):708-14. [Medline].

  31. Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology (Oxford). Aug 2011;50(8):1390-4. [Medline].

  32. Hemady RK, Baer JC, Foster CS. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin. 1992;32(1):241-52. [Medline].

  33. Hofley P, Roarty J, McGinnity G, Griffiths AM, Marcon M, Kraft S, et al. Asymptomatic uveitis in children with chronic inflammatory bowel diseases. J Pediatr Gastroenterol Nutr. Nov 1993;17(4):397-400. [Medline].

  34. Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. Oct 1984;91(10):1247-52. [Medline].

  35. Leirisalo-Repo M. Enteropathic arthritis, Whipple's disease, juvenile spondyloarthropathy, and uveitis. Curr Opin Rheumatol. Jul 1994;6(4):385-90. [Medline].

  36. Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children. A pediatric rheumatology perspective. Am J Ophthalmol. Jun 2003;135(6):879-84. [Medline].

  37. Rennebohm RM, Burke MJ, Crowe W, Levinson JE. Anterior uveitis in Kawasaki's disease. Am J Ophthalmol. Apr 1981;91(4):535-7. [Medline].

  38. Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. Dec 2004;111(12):2299-306. [Medline].

  39. Shore A, Ansell BM. Juvenile psoriatic arthritis--an analysis of 60 cases. J Pediatr. Apr 1982;100(4):529-35. [Medline].

  40. Tay-Kearney ML, Schwam BL, Lowder C, Dunn JP, Meisler DM, Vitale S, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. Jan 1996;121(1):47-56. [Medline].

  41. Weinreb RN, Tessler H. Laboratory diagnosis of ophthalmic sarcoidosis. Surv Ophthalmol. May-Jun 1984;28(6):653-64. [Medline].

  42. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. Oct 1987;94(10):1242-8. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.